WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

*Dr. Mohammed Niyazi Gheni, Dr. Luqman Mohammed Azeez, Dr. Janan Wadea Hurmiz Zora

ABSTRACT

Background and Objectives: One of the most dreaded and likely most common pain disorders is postoperative pain, which is frequently still not appropriately addressed. Our goal is to evaluate the analgesic efficacy and side effects of intravenous tramadol against local wound infiltration in adult patients following open inguinal hernia surgeries. Patients And Methods: Fifty adult male patients were randomly assigned to two groups; SC group (n=25) received tramadol 2 mg/kg titrated with NaCl 0.9% for a total of 20 mL, as a local wound infiltration prior to skin closure and IV group (n=25) received tramadol 2 mg/kg plus NaCl 0.9% to a volume of 50 mL was infused slowly within 15 minutes prior to skin closure. Postoperatively; pain severity, time to first analgesic requirement, analgesic consumption, and incidence of nausea &vomiting were recorded. Results: Over the course of the investigation, the IV group's VAS ratings were higher. The results showed that these scores were extremely significant at 3 hours and up to 24 hours (p = 0.00). Only one case (4.0%) in the SC group and four cases (16.0%) in the IV group needed diclofenac. Over the course of the trial, nausea and vomiting were less common in the SC group (p value = 0.00). Conclusions: In comparison to intravenous administration following open inguinal hernia procedures, subcutaneous wound infiltration of tramadol results in fewer cases of nausea and vomiting and a lower consumption of postoperative analgesics.